Several observations have been made in different types of cancer to find the microbial key of the disease
Insurance and Authorization With Klinic Navigating insurance for weight loss medications can be daunting
Commonly reported GLP-1 adverse effectsincluding nausea, vomiting, constipation, and abdominal discomfortsubstantially overlap with symptoms of an IBD flare, which may complicate safety monitoring and clinical assessment
GLP-1RAs contributes to weight loss and lower glycosylated hemoglobin (HbA1c), and has a renal protective effect and is preferred in patients with higher cardiovascular risk T2DM and those considering weight loss (Ng et al., 2022)
10.3389/fnut.2022.899746 161
However, visceral abdominal fat often responds well to treatment due to its high metabolic activity and sensitivity to hormonal changes that occur during weight loss